GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seres Therapeutics Inc (STU:1S90) » Definitions » Other Stockholders Equity

Seres Therapeutics (STU:1S90) Other Stockholders Equity : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Seres Therapeutics Other Stockholders Equity?

Seres Therapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €0.00 Mil.

Seres Therapeutics's quarterly Other Stockholders Equity declined from Jun. 2024 (€0.00 Mil) to Sep. 2024 (€-0.00 Mil) but then increased from Sep. 2024 (€-0.00 Mil) to Dec. 2024 (€0.00 Mil).

Seres Therapeutics's annual Other Stockholders Equity increased from Dec. 2022 (€-0.00 Mil) to Dec. 2023 (€-0.00 Mil) and increased from Dec. 2023 (€-0.00 Mil) to Dec. 2024 (€0.00 Mil).


Seres Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Seres Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seres Therapeutics Other Stockholders Equity Chart

Seres Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Seres Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Seres Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Seres Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Seres Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Seres Therapeutics Business Description

Traded in Other Exchanges
Address
101 Cambridgepark Drive, Cambridge, MA, USA, 02140
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

Seres Therapeutics Headlines

No Headlines